These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31605121)

  • 1. RADIATION PROTECTION IN THE RELEASE OF PATIENTS RECEIVING 131I TREATMENT.
    Mattar E; Salih MA; Alsafi K; Suliman II
    Radiat Prot Dosimetry; 2019 Dec; 187(4):499-508. PubMed ID: 31605121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation dose to family members of hyperthyroidism and thyroid cancer patients treated with 131I.
    Pant GS; Sharma SK; Bal CS; Kumar R; Rath GK
    Radiat Prot Dosimetry; 2006; 118(1):22-7. PubMed ID: 16105892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential third-party radiation exposure from outpatients treated with 131I for hyperthyroidism.
    Matheoud R; Reschini E; Canzi C; Voltini F; Gerundini P
    Med Phys; 2004 Dec; 31(12):3194-200. PubMed ID: 15651602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation protection issues of treating hyperthyroidism with 131 I in patients on haemodialysis.
    Homer L; Smith AH
    Nucl Med Commun; 2002 Mar; 23(3):261-4. PubMed ID: 11891485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective study on the transition of radiation dose rate and iodine distribution in patients with I-131-treated well-differentiated thyroid cancer to improve bed control shorten isolation periods.
    Yama N; Sakata K; Hyodoh H; Tamakawa M; Hareyama M
    Ann Nucl Med; 2012 Jun; 26(5):390-6. PubMed ID: 22382609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new proposal for monitoring patients in nuclear medicine.
    Willegaignon J; Guimarães MI; Sapienza MT; Stabin MG; Malvestiti LF; Marone M; Sordi GM
    Health Phys; 2006 Dec; 91(6):624-9. PubMed ID: 17099406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating radiation absorbed dose of individuals nearby 131I-treated hyperthyroid patients.
    Cui S; Jiao L; Tan J; Zhang G; Zhang H; Long W; Fan S; Zhang W
    Health Phys; 2014 Mar; 106(3):365-9. PubMed ID: 25208013
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Brudecki K; Kluczewska-Gałka A; Zagrodzki P; Jarząb B; Gorzkiewicz K; Mróz T
    Radiat Environ Biophys; 2020 Aug; 59(3):559-564. PubMed ID: 32564132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimated dose rates to members of the public from external exposure to patients with 131I thyroid treatment.
    Dewji S; Bellamy M; Hertel N; Leggett R; Sherbini S; Saba M; Eckerman K
    Med Phys; 2015 Apr; 42(4):1851-7. PubMed ID: 25832075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction factors for more accurate estimates of exposure rates near radioactive patients: experimental, point, and line source models.
    Willegaignon J; Guimarães MI; Stabin MG; Sapienza MT; Malvestiti LF; Marone MM; Sordi GM
    Health Phys; 2007 Dec; 93(6):678-88. PubMed ID: 17993848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid cancer: radiation safety precautions in 131I therapy based on actual biokinetic measurements.
    Liu B; Peng W; Huang R; Tian R; Zeng Y; Kuang A
    Radiology; 2014 Oct; 273(1):211-9. PubMed ID: 24895877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Problems with radiation protection for adjuvant radiotherapy of thyroid cancer].
    Siekierzyński M
    Wiad Lek; 2001; 54 Suppl 1():307-11. PubMed ID: 12182040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation exposure from outpatient radioactive iodine (131I) therapy for thyroid carcinoma.
    Grigsby PW; Siegel BA; Baker S; Eichling JO
    JAMA; 2000 May; 283(17):2272-4. PubMed ID: 10807387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occupational exposure and radiobiological risk from thyroid radioiodine therapy in Saudi Arabia.
    Al-Mohammed HI; Sulieman A; Mayhoub FH; Salah H; Lagarde C; Alkhorayef M; Aldhebaib A; Kappas C; Bradley DA
    Sci Rep; 2021 Jul; 11(1):14557. PubMed ID: 34267237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatic differentiated thyroid cancer.
    de Keizer B; Hoekstra A; Konijnenberg MW; de Vos F; Lambert B; van Rijk PP; Lips CJ; de Klerk JM
    J Nucl Med; 2004 Sep; 45(9):1549-54. PubMed ID: 15347723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation Between Exposure Rate and Residual Activity in Felines Undergoing 131I Thyroid Ablation Therapy.
    Martin TM; Vasudevan L; Chirayath SS
    Health Phys; 2015 Aug; 109(2):95-103. PubMed ID: 26107429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid cancer patients treated with 131I: radiation dose to relatives after discharge from the hospital.
    Rémy H; Coulot J; Borget I; Ricard M; Guilabert N; Lavielle F; Camps E; Baudin E; Lumbroso J; Leboulleux S; Schlumberger M
    Thyroid; 2012 Jan; 22(1):59-63. PubMed ID: 22136157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation exposure rate from 131I-treated hyperthyroid patients--a dynamic study, with data for up to 42 d post therapy.
    Mohammadi H
    Health Phys; 2005 May; 88(5):486-90. PubMed ID: 15824597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 131-Iodine capsules in thyroid therapy: an individually controlled study of their uptake kinetics as compared to liquid 131-iodine.
    von Schulthess GK; Seelentag WW; Pfeiffer G; Blaeuenstein P; Bekier A
    Eur J Nucl Med; 1985; 10(1-2):25-8. PubMed ID: 3838513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe?
    de Carvalho JW; Sapienza M; Ono C; Watanabe T; Guimarães MI; Gutterres R; Marechal MH; Buchpiguel C
    Nucl Med Commun; 2009 Jul; 30(7):533-41. PubMed ID: 19436231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.